Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

Analysts anticipate Exact Sciences to report an earnings per share (EPS) of $0.02. Anticipation surrounds Exact Sciences's ...

Cologuard Classic will "make a couple tweaks to make the fan experience even better, but I think we have some good bones in place for the next three years" at hard-walking La Paloma Country Club.

LaMontagne will lead the commercial rollout of the company’s groundbreaking early-stage cancer detection test, Certitude.

Pandemic-era restrictions meant that last year’s Cologuard Classic lacked much of the ambience that goes into a professional golf tournament. This year, the Cologuard Classic won’t be limiting ...

University research in Wisconsin led to $500 million Third Wave business, screening tests for cancer, including Cologuard ...

James Van Der Beek was diagnosed with colon cancer in 2023. He hopes more people will get screened earlier with the new ...

Handheld saliva test detects breast cancer and even identifies its type, University of Florida researchers say. The device ...

Van Der Beek offered a reminder that colorectal cancer is one of the most curable types of cancer when it’s caught early and ...

Thursday, July 31, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Costco ...